Beacon Hospice, An Amedisys Company 289 State Street, Suite B, Bangor, ME, 04401 | |
(207) 942-2920 |
News Archive
Pathologists at The University of Texas Health Science Center at Houston have developed a chemically modified protein that may help people with a hard-to-treat form of a genetic bleeding disorder known as Hemophilia A. The discovery and the results of pre-clinical tests appear in the May 2 issue of the Journal of Biological Chemistry.
A recent study by National University of Singapore (NUS) researchers revealed that Asian breast cancer patients who had received or were undergoing chemotherapy treatment showed symptoms of "chemobrain", in which they encounter memory loss, difficulty in decision making and speech problems.
ADEC Solutions, an end-to-end business process outsourcing (BPO) global market provider of customized outsourcing solutions, announced a partnership agreement with Zuellig Pharma, uniting the two companies to create a global pharmaceutical and healthcare-focused knowledge process outsourcing (KPO) and BPO powerhouse.
Frontier Medical Group, the specialist medical device manufacturer, has been named Wales Mid-Market Team of the Year at the prestigious British Private Equity & Venture Capital Association (BVCA) Management Team Awards 2016.
› Verified 1 days ago
Name | Beacon Hospice, An Amedisys Company |
---|---|
Location | 289 State Street, Suite B, Bangor, Maine |
Hospice ID | 201520 |
Category | Freestanding Hospice |
Ownership Type | Other |
Profit Type | OTHER |
SSA county code | 090 |
News Archive
Pathologists at The University of Texas Health Science Center at Houston have developed a chemically modified protein that may help people with a hard-to-treat form of a genetic bleeding disorder known as Hemophilia A. The discovery and the results of pre-clinical tests appear in the May 2 issue of the Journal of Biological Chemistry.
A recent study by National University of Singapore (NUS) researchers revealed that Asian breast cancer patients who had received or were undergoing chemotherapy treatment showed symptoms of "chemobrain", in which they encounter memory loss, difficulty in decision making and speech problems.
ADEC Solutions, an end-to-end business process outsourcing (BPO) global market provider of customized outsourcing solutions, announced a partnership agreement with Zuellig Pharma, uniting the two companies to create a global pharmaceutical and healthcare-focused knowledge process outsourcing (KPO) and BPO powerhouse.
Frontier Medical Group, the specialist medical device manufacturer, has been named Wales Mid-Market Team of the Year at the prestigious British Private Equity & Venture Capital Association (BVCA) Management Team Awards 2016.
› Verified 1 days ago
NPI Number | 1245444280 |
Organization Name | Beacon Hospice, Llc |
Address | 289 State St Bangor, Maine, 04401 |
Phone Number | (207)942-2920 |
News Archive
Pathologists at The University of Texas Health Science Center at Houston have developed a chemically modified protein that may help people with a hard-to-treat form of a genetic bleeding disorder known as Hemophilia A. The discovery and the results of pre-clinical tests appear in the May 2 issue of the Journal of Biological Chemistry.
A recent study by National University of Singapore (NUS) researchers revealed that Asian breast cancer patients who had received or were undergoing chemotherapy treatment showed symptoms of "chemobrain", in which they encounter memory loss, difficulty in decision making and speech problems.
ADEC Solutions, an end-to-end business process outsourcing (BPO) global market provider of customized outsourcing solutions, announced a partnership agreement with Zuellig Pharma, uniting the two companies to create a global pharmaceutical and healthcare-focused knowledge process outsourcing (KPO) and BPO powerhouse.
Frontier Medical Group, the specialist medical device manufacturer, has been named Wales Mid-Market Team of the Year at the prestigious British Private Equity & Venture Capital Association (BVCA) Management Team Awards 2016.
› Verified 1 days ago
Quality Measure | Provider Score | National Score |
---|---|---|
Patients or caregivers who were asked about treatment preferences like hospitalization and resuscitation at the beginning of hospice care | 99.1 | 98.3 |
Patients or caregivers who were asked about their beliefs and values at the beginning of hospice care | 99.3 | 93.6 |
Patients who were checked for pain at the beginning of hospice care | 96.8 | 93.9 |
Patients who got a timely and thorough pain assessment when pain was identified as a problem | 88.0 | 77.7 |
Patients who were checked for shortness of breath at the beginning of hospice care | 99.3 | 97.3 |
Patients who got timely treatment for shortness of breath | 77.3 | 94.6 |
Patients taking opioid pain medication who were offered care for constipation | 98.4 | 93.3 |
News Archive
Pathologists at The University of Texas Health Science Center at Houston have developed a chemically modified protein that may help people with a hard-to-treat form of a genetic bleeding disorder known as Hemophilia A. The discovery and the results of pre-clinical tests appear in the May 2 issue of the Journal of Biological Chemistry.
A recent study by National University of Singapore (NUS) researchers revealed that Asian breast cancer patients who had received or were undergoing chemotherapy treatment showed symptoms of "chemobrain", in which they encounter memory loss, difficulty in decision making and speech problems.
ADEC Solutions, an end-to-end business process outsourcing (BPO) global market provider of customized outsourcing solutions, announced a partnership agreement with Zuellig Pharma, uniting the two companies to create a global pharmaceutical and healthcare-focused knowledge process outsourcing (KPO) and BPO powerhouse.
Frontier Medical Group, the specialist medical device manufacturer, has been named Wales Mid-Market Team of the Year at the prestigious British Private Equity & Venture Capital Association (BVCA) Management Team Awards 2016.
› Verified 1 days ago
Home Health Aides | 16 |
Counselors | 2.25 |
Licensed Practical or Vocational Nurses | 1 |
Medical Social Workers | 2.75 |
Registered Nurses | 18.25 |
Other Personnel | 10 |
Total Employees | 50.25 |
---|
News Archive
Pathologists at The University of Texas Health Science Center at Houston have developed a chemically modified protein that may help people with a hard-to-treat form of a genetic bleeding disorder known as Hemophilia A. The discovery and the results of pre-clinical tests appear in the May 2 issue of the Journal of Biological Chemistry.
A recent study by National University of Singapore (NUS) researchers revealed that Asian breast cancer patients who had received or were undergoing chemotherapy treatment showed symptoms of "chemobrain", in which they encounter memory loss, difficulty in decision making and speech problems.
ADEC Solutions, an end-to-end business process outsourcing (BPO) global market provider of customized outsourcing solutions, announced a partnership agreement with Zuellig Pharma, uniting the two companies to create a global pharmaceutical and healthcare-focused knowledge process outsourcing (KPO) and BPO powerhouse.
Frontier Medical Group, the specialist medical device manufacturer, has been named Wales Mid-Market Team of the Year at the prestigious British Private Equity & Venture Capital Association (BVCA) Management Team Awards 2016.
› Verified 1 days ago
Others | 28 |
Total Volunteers | 28 |
---|
News Archive
Pathologists at The University of Texas Health Science Center at Houston have developed a chemically modified protein that may help people with a hard-to-treat form of a genetic bleeding disorder known as Hemophilia A. The discovery and the results of pre-clinical tests appear in the May 2 issue of the Journal of Biological Chemistry.
A recent study by National University of Singapore (NUS) researchers revealed that Asian breast cancer patients who had received or were undergoing chemotherapy treatment showed symptoms of "chemobrain", in which they encounter memory loss, difficulty in decision making and speech problems.
ADEC Solutions, an end-to-end business process outsourcing (BPO) global market provider of customized outsourcing solutions, announced a partnership agreement with Zuellig Pharma, uniting the two companies to create a global pharmaceutical and healthcare-focused knowledge process outsourcing (KPO) and BPO powerhouse.
Frontier Medical Group, the specialist medical device manufacturer, has been named Wales Mid-Market Team of the Year at the prestigious British Private Equity & Venture Capital Association (BVCA) Management Team Awards 2016.
› Verified 1 days ago
St. Joseph Hospice Location: 279 Center Street, Bangor, Maine, 04401 Phone: (207) 942-2920 |
Hospice Of Eastern Maine Location: 855 Union Street, Ste 220, Bangor, Maine, 04402 Phone: (207) 942-2920 |
Community Health & Counseling Services Location: 42 Cedar Street, Bangor, Maine, 04401 Phone: (207) 942-2920 |
Beacon Hospice, An Amedisys Company Location: 289 State Street, Suite B, Bangor, Maine, 04401 Phone: (207) 942-2920 |